K2 Principal Fund’s Bausch Health BHC Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2022
Q2
Sell
-178,400
Closed -$4.08M 357
2022
Q1
$4.08M Buy
178,400
+7,400
+4% +$181K 0.35% 68
2021
Q4
$4.72M Sell
171,000
-273,800
-62% -$7.33M 0.31% 74
2021
Q3
$12.4M Buy
444,800
+394,800
+790% +$11.2M 1.01% 18
2021
Q2
$1.47M Buy
+50,000
New +$1.51M 0.12% 204
2021
Q1
Sell
-245,000
Closed -$5.1M 303
2020
Q4
$5.1M Buy
245,000
+195,000
+390% +$3.64M 0.45% 59
2020
Q3
$777K Sell
50,000
-217,700
-81% -$3.75M 0.12% 171
2020
Q2
$4.9M Buy
267,700
+207,700
+346% +$3.66M 0.78% 38
2020
Q1
$930K Buy
+60,000
New +$1.45M 0.18% 115
2016
Q1
Sell
-10,000
Closed -$1.02M 220
2015
Q4
$1.02M Buy
+10,000
New +$1.12M 0.14% 113

Other funds holding BHC

K2 Principal Fund's BHC Position: Q1 2022 in Review

K2 Principal Fund sold out of Bausch Health (BHC) in Q1 2022, closing a stake of 83,238 shares — an estimated $2.03M sold.

K2 Principal Fund first reported a position in BHC in Q3 2020 and held it in 3 quarters. The position peaked at $2.3M in Q4 2021. 370 funds tracked by Wall St. Rank hold BHC as of Q1 2022.

  • K2 Principal Fund reported no remaining Bausch Health position as of Q1 2022 after selling out during the quarter.
  • K2 Principal Fund sold 83,238 Bausch Health shares in Q1 2022, an estimated $2.03M.
  • K2 Principal Fund first reported a position in Bausch Health in Q3 2020 and held it in 3 quarters.
  • K2 Principal Fund's Bausch Health position peaked at $2.3M in Q4 2021.
  • 370 funds tracked by Wall St. Rank held Bausch Health as of Q1 2022.

Based on K2 Principal Fund's 13F filing for Q1 2022, filed 16 May 2022.